Institute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
Department of Infectious Diseases, Institute of Virology, University Hospital Heidelberg, Heidelberg, Germany.
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01056-18. Print 2018 Sep 1.
Herpesvirus infections are highly prevalent in the human population and persist for life. They are often acquired subclinically but potentially progress to life-threatening diseases in immunocompromised individuals. The interferon system is indispensable for the control of herpesviral replication. However, the responsible antiviral effector mechanisms are not well characterized. The type I interferon-induced, human myxovirus resistance 2 () gene product MxB, a dynamin-like large GTPase, has recently been identified as a potent inhibitor of HIV-1. We now show that MxB also interferes with an early step of herpesvirus replication, affecting alpha-, beta-, and gammaherpesviruses before or at the time of immediate early gene expression. Defined MxB mutants influencing GTP binding and hydrolysis revealed that the effector mechanism against herpesviruses is thoroughly different from that against HIV-1. Overall, our findings demonstrate that MxB serves as a broadly acting intracellular restriction factor that controls the establishment of not only retrovirus but also herpesvirus infection of all three subfamilies. Human herpesviruses pose a constant threat to human health. Reactivation of persisting herpesvirus infections, particularly in immunocompromised individuals and the elderly, can cause severe diseases, such as zoster, pneumonia, encephalitis, or cancer. The interferon system is relevant for the control of herpesvirus replication as exemplified by fatal disease outcomes in patients with primary immunodeficiencies. Here, we describe the interferon-induced, human gene product MxB as an efficient restriction factor of alpha-, beta-, and gammaherpesviruses. MxB has previously been described as an inhibitor of HIV-1. Importantly, our mutational analyses of MxB reveal an antiviral mechanism of herpesvirus restriction distinct from that against HIV-1. Thus, the dynamin-like MxB GTPase serves as a broadly acting intracellular restriction factor that controls retrovirus as well as herpesvirus infections.
疱疹病毒感染在人类中非常普遍,并终身存在。它们通常在亚临床状态下被获得,但在免疫功能低下的个体中可能会进展为危及生命的疾病。干扰素系统对于控制疱疹病毒复制是不可或缺的。然而,负责的抗病毒效应机制尚未得到很好的描述。I 型干扰素诱导的人黏液瘤病毒抗性 2()基因产物 MxB,一种类似于动力蛋白的大 GTP 酶,最近被鉴定为 HIV-1 的有效抑制剂。我们现在表明,MxB 还干扰疱疹病毒复制的早期步骤,在即刻早期基因表达之前或同时影响α、β和γ疱疹病毒。影响 GTP 结合和水解的定义的 MxB 突变体表明,针对疱疹病毒的效应机制与针对 HIV-1 的机制完全不同。总体而言,我们的研究结果表明,MxB 作为一种广泛作用的细胞内限制因子,不仅可以控制逆转录病毒的建立,还可以控制所有三个亚科的疱疹病毒感染。人类疱疹病毒对人类健康构成持续威胁。潜伏疱疹病毒感染的再激活,特别是在免疫功能低下的个体和老年人中,可导致严重疾病,如带状疱疹、肺炎、脑炎或癌症。干扰素系统对于控制疱疹病毒复制很重要,例如原发性免疫缺陷患者的致命疾病结局就是例证。在这里,我们描述了干扰素诱导的人类基因产物 MxB 作为α、β和γ疱疹病毒的有效限制因子。MxB 先前被描述为 HIV-1 的抑制剂。重要的是,我们对 MxB 的突变分析揭示了一种与针对 HIV-1 的机制不同的疱疹病毒限制的抗病毒机制。因此,类似于动力蛋白的 MxB GTP 酶作为一种广泛作用的细胞内限制因子,可控制逆转录病毒和疱疹病毒感染。